SLC25A39 potentiates the RXFP1/cAMP/PKA/CREB axis to drive metabolic reprogramming and tumor progression in ovarian cancer

Cell Biology and Toxicology · Published 2026-08-03 · DOI 10.1007/s10565-026-10236-6

Free full text

Authors (8)

Tian Tian, Jiming Bai, Qian Li, Qing Li, Shumin Kang, Qiong Wu, Penghua Cui, Suwei Lan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Tian, T., Bai, J., Li, Q., et al. (2026). SLC25A39 potentiates the RXFP1/cAMP/PKA/CREB axis to drive metabolic reprogramming and tumor progression in ovarian cancer. Cell Biology and Toxicology. https://doi.org/10.1007/s10565-026-10236-6

Related articles